Chemiesynth Vapi opened lower at -, compared with its previous close of ₹160.70. In the last trading session on 12 Nov 2026, the stock traded between - and -, with an average traded price of -. It showed a sideways intraday trend.
An investment of ₹10,000 made 5 years ago in Chemiesynth Vapi is now worth
₹ 1,07,133.00
Giving a profit of
₹ 97,133.00 (971.33%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+0.00 (+0.00%)
Day High
-
Day Low
-
Day Open
-
Prev Close
₹160.70
Volume
-
Value Traded
-
1W Return
4.97%
1M Return
40.64%
3M Return
88.47%
6M Return
178.27%
1Y Return
251.45%
Market Cap (₹ Cr.)
49
PE Ratio
-59.10
PB Ratio
5.30
Dividend Yield
-
ROE
-9.84%
ROCE
-0.31%
Book Value (₹)
30.33
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
4.97%
6 Weeks
-
1 Month
40.64%
3 Months
88.47%
9 Months
115.84%
No data available.
Chemiesynth (Vapi) publishes Q2FY27 results; net loss narrows 64% YoY
Chemiesynth (Vapi) narrowed Q2FY27 net loss to ₹15.89 lakh, down 63.8% YoY. Revenue from operations contracted 22.6% YoY to ₹531.98 lakh. Results published in Indian Express and Financial Express on November 5, 2026. Inventories surged to ₹440.11 lakh, driving negative operating cash flows.
6 days agoChemiesynth Vapi allots ₹10 crore unlisted NCRPS on private placement
Chemiesynth (Vapi) Limited allotted 1 crore unlisted NCRPS on a private placement basis. The total issue size aggregates to ₹10 crore with an issue price of ₹10 per share. The preference shares carry a 5% annual coupon and have a seven-year tenure. Maturity is set for October 28, 2033, with put and call options exercisable after two years.
15 days agoChemiesynth shareholders adopt FY26 results, approve ₹15 cr preference issue
All 18 resolutions at the 40th AGM passed unanimously by shareholders. Authorized share capital increased from ₹3.25 crore to ₹18.25 crore. Approval granted for issuing up to ₹15 crore in 5% non-convertible preference shares. Related party transaction limits raised for group entities up to ₹15 crore annually.
1mo agoChemiesynth Vapi schedules AGM for Sept 30, seeks approval for ₹15cr NCRPS
Chemiesynth Vapi schedules 40th AGM for September 30, 2026. Board proposes ₹15 crore NCRPS issue at ₹10 per share. Related-party transaction limits capped at ₹36 crore for FY27. Authorised share capital to increase from ₹3.25 crore to ₹18.25 crore.
2mo agoChemiesynth Vapi Q1 Results: Net Loss Widens To ₹58.4 Lakh
Chemiesynth (Vapi) Ltd posted a Q1FY26 net loss of ₹58.37 lakh on revenue of ₹419.69 lakh. The Board approved raising authorized capital to ₹18.25 crore and issuing ₹15 crore in unlisted 5% NCRPS. The AGM is set for September 30, 2026.
3mo agoChemiesynth Vapi reports FY26 loss of ₹98.93 lakh
Chemiesynth (Vapi) Limited reported a widened net loss of ₹98.93 lakh for FY26 compared to ₹10.62 lakh in FY25, despite revenue from operations rising to ₹2144.87 lakh. The company achieved a net profit of ₹60.36 lakh in Q4FY26. The audited financial results were approved by the Board on May 27, 2026, and published in newspapers on May 28, 2026.
5mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹19,420.00 | +0.75% | ₹1,75,731.69 | 74.40 | +37.89% | |
| ₹1,550.50 | -1.85% | ₹1,57,822.25 | 59.10 | +4.62% | |
| ₹2,472.50 | -0.18% | ₹73,291.04 | 32.30 | -15.94% | |
| ₹6,823.00 | +0.27% | ₹58,189.43 | 117.40 | +17.62% | |
| ₹4,776.10 | -0.79% | ₹52,465.46 | 79.80 | +29.10% | |
| ₹10,060.50 | +0.92% | ₹51,602.69 | 56.20 | +67.05% | |
| ₹557.30 | -0.93% | ₹28,119.92 | 33.00 | +21.20% | |
| ₹1,671.20 | -1.08% | ₹22,181.48 | 89.90 | +124.73% | |
| ₹1,602.80 | -1.38% | ₹21,861.08 | 20.90 | -7.14% | |
| ₹484.35 | +0.09% | ₹17,562.26 | 29.60 | +21.97% | |
| ₹5,339.00 | +0.12% | ₹16,369.36 | 34.00 | +25.06% | |
| ₹1,246.30 | -0.93% | ₹15,733.02 | 16.10 | -10.54% |
An investment of ₹10,000 made 5 years ago in Chemiesynth Vapi is now worth
₹ 1,07,133.00
Giving a profit of
₹ 97,133.00 (971.33%)
Note: Past profits do not guarantee future returns.
